Hypertension
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-06-01
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:22
Label at a glance#
ProductHypertension
Active ingredientMicrurus Corallinus Venom, Epinephrine, Arsenic Triiodide, Gold, Barium Carbonate, Bryonia Alba Root, Selenicereus Grandiflorus Stem, Chelidonium Majus, Cinchona Officinalis Bark, Crotalus Horridus Horridus Venom, Digitalis, Nitroglycerin, Potassium Carbonate, Potassium Iodide, Lachesis Muta Venom, Naja Naja Venom, Strychnos Nux-vomica Seed, Veratrum Album Root, Vipera Berus Venom, Viscum Album Fruiting Top, Ruta Graveolens Flowering Top, Valerian
Label structure10 sections
Contacts and useful links#
Websitewww.newtonlabs.net
www.newtonlabs.net
www.newtonlabs.netLabel contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
HYPERTENSION Formulated for symptoms including headache, elevated B/P readings, tinnitus, anxiety, depression, sweating, pallor and nausea.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally one to four times daily or as directed by a healthcare professional.
ACTIVE INGREDIENT SECTION
Elaps corallinus 30x, Adrenalinum 15x, Arsenicum iodatum 15x, Aur. met. 15x, Baryta carb. 15x, Bryonia 15x, Cactus 15x, Chelidonium majus 15x, Cinchona 15x, Crotalus horridus 15x, Digitalis 15x, Glonoinum 15x, Kali carb. 15x, Kali iod. 15x, Lachesis 15x, Naja 15x, Nux vom. 15x, Veratrum alb. 15x, Vipera berus 15x, Viscum 15x, Ruta 3x, Valeriana 3x.
PURPOSE SECTION
Formulated for symptoms including headache, elevated B/P readings, tinnitus, anxiety, depression, sweating, pallor and nausea.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS? SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant or nursing or if symptoms worsen or persist for more than a few days.
KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-4425-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f194-f424-e053-dadaa90a57ce | Hypertension |
| 55714-4425-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f194-f424-e053-dadaa90a57ce | Hypertension |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55714-4425-1 | Hypertension | 28.35 g in 1 BOTTLE, GLASS | PELLET | 28.35 | 1 | |
| 55714-4425-2 | Hypertension | 56.7 g in 1 BOTTLE, GLASS | PELLET | 56.7 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-4425 | HYPERTENSION (ELAPS CORALLINUS, ADRENALINUM, ARSENICUM IODATUM , AUR. MET., BARYTA CARB., BRYONIA, CACTUS, CHELIDONIUM MAJUS, CINCHONA, CROTALUS HORRIDUS, DIGITALIS, GLONOINUM, KALI CARB., KALI IOD ., LACHESIS , NAJA , NUX VOM., VERATRUM ALB., VIPERA BERUS, VISCUM, RUTA, VALERIANA) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC, 2 package rows | 20140108_d5035a9b-0c78-48fe-7961-0d151deec686.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Arsenic Triiodide | ACTIVE INGREDIENT | 3029988O2T | 1 | |
| Barium Carbonate | ACTIVE INGREDIENT | 6P669D8HQ8 | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| Cinchona Officinalis Bark | ACTIVE INGREDIENT | S003A158SB | 1 | |
| Crotalus Horridus Horridus Venom | ACTIVE INGREDIENT | YHA2XLJ956 | 1 | |
| Digitalis | ACTIVE INGREDIENT | F1T8QT9U8B | 1 | |
| Epinephrine | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| Gold | ACTIVE INGREDIENT | 79Y1949PYO | 1 | |
| Lachesis Muta Venom | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| Micrurus Corallinus Venom | ACTIVE INGREDIENT | V0S6H36980 | 1 | |
| Naja Naja Venom | ACTIVE INGREDIENT | ZZ4AG7L7VM | 1 | |
| Nitroglycerin | ACTIVE INGREDIENT | G59M7S0WS3 | 1 | |
| Potassium Carbonate | ACTIVE INGREDIENT | BQN1B9B9HA | 1 | |
| Potassium Iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| Ruta Graveolens Flowering Top | ACTIVE INGREDIENT | N94C2U587S | 1 | |
| Selenicereus Grandiflorus Stem | ACTIVE INGREDIENT | 7114SV0MYK | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Valerian | ACTIVE INGREDIENT | JWF5YAW3QW | 1 | |
| Veratrum Album Root | ACTIVE INGREDIENT | QNS6W5US1Z | 1 | |
| Vipera Berus Venom | ACTIVE INGREDIENT | 0ORO6NCA4M | 1 | |
| Viscum Album Fruiting Top | ACTIVE INGREDIENT | BK9092J5MP | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Barium Cation | ACTIVE MOIETY | V645272HLN | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Carbonate Ion | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| Cinchona Officinalis Bark | ACTIVE MOIETY | S003A158SB | 1 | |
| Crotalus Horridus Horridus Venom | ACTIVE MOIETY | YHA2XLJ956 | 1 | |
| Digitalis | ACTIVE MOIETY | F1T8QT9U8B | 1 | |
| Epinephrine | ACTIVE MOIETY | YKH834O4BH | 1 | |
| Gold | ACTIVE MOIETY | 79Y1949PYO | 1 | |
| Iodide Ion | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| Lachesis Muta Venom | ACTIVE MOIETY | VSW71SS07I | 1 | |
| Micrurus Corallinus Venom | ACTIVE MOIETY | V0S6H36980 | 1 | |
| Naja Naja Venom | ACTIVE MOIETY | ZZ4AG7L7VM | 1 | |
| Nitroglycerin | ACTIVE MOIETY | G59M7S0WS3 | 1 | |
| Ruta Graveolens Flowering Top | ACTIVE MOIETY | N94C2U587S | 1 | |
| Selenicereus Grandiflorus Stem | ACTIVE MOIETY | 7114SV0MYK | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Valerian | ACTIVE MOIETY | JWF5YAW3QW | 1 | |
| Veratrum Album Root | ACTIVE MOIETY | QNS6W5US1Z | 1 | |
| Vipera Berus Venom | ACTIVE MOIETY | 0ORO6NCA4M | 1 | |
| Viscum Album Fruiting Top | ACTIVE MOIETY | BK9092J5MP | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Hypertension
- Elaps corallinus, Adrenalinum, Arsenicum iodatum , Aur. met., Baryta carb., Bryonia, Cactus, Chelidonium majus, Cinchona, Crotalus horridus, Digitalis, Glonoinum, Kali carb., Kali iod ., Lachesis , Naja , Nux vom., Veratrum alb., Vipera berus, Viscum, Ruta, Valeriana
- Micrurus Corallinus Venom
- Epinephrine
- Arsenic Triiodide
- Arsenic Cation (3+)
- Gold
- Barium Carbonate
- Barium Cation
- Bryonia Alba Root
- Selenicereus Grandiflorus Stem
- Chelidonium Majus
- Cinchona Officinalis Bark
- Crotalus Horridus Horridus Venom
- Digitalis
- Nitroglycerin
- Potassium Carbonate
- Carbonate Ion
- Potassium Iodide
- Iodide Ion
- Lachesis Muta Venom
- Naja Naja Venom
- Strychnos Nux-vomica Seed
- Veratrum Album Root
- Vipera Berus Venom
- Viscum Album Fruiting Top
- Ruta Graveolens Flowering Top
- Valerian
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-4425 | 55714-4425-1, 55714-4425-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d0ae71ca-571d-8cd5-9542-93ade77dc7bc | d5035a9b-0c78-48fe-7961-0d151deec686 | 2011-06-01 | Warnings | d0ae71ca-571d-8cd5-9542-93ade77dc7bc d5035a9b-0c78-48fe-7961-0d151deec686 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.